Clinical Performance Improvement in Diabetes: Adapting a Proven Model in Dubai

Abstract

The Dubai Performance Improvement (P.I.) project in Diabetes (Dubai-PID) will replicate the 6-phase process used in the European Performance Improvement in Diabetes Demonstration project (EPIDD), an initiative deployed in the region of Cantabria, Spain. Dubai-PID will aim to improve clinical practice of primary care teams treating and managing Type 2 Diabetes (T2D) patients in Dubai. The project will begin with the formation of a Triple Helix collaborative between a private P.I. organisation (AXDEV), academia (Mohammed Bin Rashid University), and industry and local governmental health authorities. Phase 1 will include the development of a collaborative agreement, defining the roles and responsibilities of each organisation, ensuring a common understanding of the project. In Phase 2, potential practice challenges will be identified from a literature review. In Phase 3, a consultation group of local healthcare providers (HCP) and decision-makers will prioritise the locally relevant challenges, which will be further validated during semi-structured interviews with HCPs. Confirmed challenges will inform case-based educational interventions designed and deployed in selected Dubai clinics during Phase 4. The ethics-approved evaluation (Phase 5) will include online surveys and qualitative interviews with learners, clinic administrators and T2D patients. The initiative will also include a dissemination plan (Phase 6), to ensure sharing of lessons learned to the professional educator and healthcare provider communities. This case will use the results and learnings from EPIDD to inform each phase, to ensure success of the initiative.

Geographic Coverage United Arab Emirates (UAE)/Emirate of Dubai/Dubai.